Skip to Content

Etomidate Injection

Last Updated: August 22, 2018
Status: Current

Products Affected - Description
    • Amidate injection, Pfizer, 2 mg/mL, 20 mL LifeShield syringe, 10 count, NDC 00409-8060-29
    • Amidate injection, Pfizer, 2 mg/mL, 20 mL vial, 10 count, NDC 00409-6695-02
    • Etomidate injection, American Regent, 2 mg/mL, 10 mL vial, 10 count, NDC 00517-0780-10
    • Etomidate injection, American Regent, 2 mg/mL, 20 mL vial, 10 count, NDC 00517-0781-10
    • Etomidate injection, Mylan Institutional, 2 mg/mL, 10 mL vial, 10 count, NDC 67457-0477-10
    • Etomidate injection, Mylan Institutional, 2 mg/mL, 20 mL vial, 10 count, NDC 67457-0456-21
Reason for the Shortage
    • American Regent did not provide a reason for the current shortage.
    • AuroMedics has etomidate available.
    • Hikma has etomidate available.
    • Mylan did not provide a reason for the current shortage.
    • Par Sterile Products discontinued etomidate in early 2015.
    • Pfizer has Amidate on shortage due to manufacturing delays. Pfizer discontinued etomidate ampules in October 2016.
    • Sagent is no longer marketing etomidate.
    • Zydus had etomidate on shortage due to an increase in demand.
Available Products
    • Amidate injection, Pfizer, 2 mg/mL, 10 mL vial, 10 count, NDC 00409-6695-01
    • Etomidate injection, Athenex, 2 mg/mL, 10 mL vial, 10 count, NDC 70860-0652-10
    • Etomidate injection, Athenex, 2 mg/mL, 20 mL vial, 10 count, NDC 70860-0652-20
    • Etomidate injection, AuroMedics, 2 mg/mL, 10 mL vial, 10 count, NDC 55150-0221-10
    • Etomidate injection, AuroMedics, 2 mg/mL, 20 mL vial, 10 count, NDC 55150-0222-20
    • Etomidate injection, Hikma, 2 mg/mL, 10 mL vial, 10 count, NDC 00143-9506-10
    • Etomidate injection, Hikma, 2 mg/mL, 20 mL vial, 10 count, NDC 00143-9507-10
    • Etomidate injection, Zydus, 2 mg/mL, 10 mL vial, 10 count, NDC 68382-0545-07
    • Etomidate injection, Zydus, 2 mg/mL, 20 mL vial, 10 count, NDC 68382-0545-08

Estimated Resupply Dates

    • American Regent has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company cannot estimate a release date.
    • Mylan Institutional has etomidate 2 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of late-October to early-November 2018.
    • Pfizer has Amidate 2 mg/mL 20 mL LifeShield syringes on back order and the company cannot estimate a release date. The 2 mg/mL 20 mL vials are on back order and the company estimates a release date of November 2018.

Safety

    • Clinicians must take extra care to ensure safe use of etomidate when using different presentations than those normally stocked.

Updated

Updated August 22, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 6, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide